Investors

Building a Biopharmaceutical Company

Investors

Lexicon Pharmaceuticals is a biopharmaceutical company focused on developing breakthrough treatments for human disease.

Stock Quote Events & Webcasts
NASDAQ: LXRX
8.84
+0.46 (+5.49%)
Range 8.21 - 8.88
Open 8.44
Prev Close 8.38
52 Week 6.09 - 15.79
Volume 606332
Market Cap 916.02M
*Delayed 2/12/2016 4:00 EDT

 
Form 8937 for 2015 Reverse Stock Split

 

Investor and Media Relations Contact
Corporate Communications and Investor Relations
Lexicon Pharmaceuticals, Inc.
8800 Technology Forest Place
The Woodlands, TX 77381-1160
281.863.3000